Burke Whitman - Omega Healthcare Independent Director
| OHI Stock | USD 40.67 0.10 0.25% |
Director
Mr. Burke W. Whitman serves as Independent Director of the company. Mr. Whitman is currently a Major General in the United States Marine Corporationration and has held various roles of increasing responsibility in the Marine Corporationration since 2008 and previously from 1985 to 1988. From 2007 to 2008, Mr. Whitman served as President, Chief Executive Officer and a director of Health Management Associates, Inc., an operator of acute care hospitals that was then listed on the New York Stock Exchange. Mr. Whitman also served as President and Chief Operating Officer of Health Management Associates from 2005 to 2007. From 1998 to 2005, Mr. Whitman was the Chief Financial Officer of Triad Hospitals, Inc since 2018.
| Age | 64 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Address | 303 International Circle, Hunt Valley, MD, United States, 21030-1394 |
| Phone | 410 427 1700 |
| Web | https://www.omegahealthcare.com |
Burke Whitman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Burke Whitman against Omega Healthcare stock is an integral part of due diligence when investing in Omega Healthcare. Burke Whitman insider activity provides valuable insight into whether Omega Healthcare is net buyers or sellers over its current business cycle. Note, Omega Healthcare insiders must abide by specific rules, including filing SEC forms every time they buy or sell Omega Healthcare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Burke Whitman over a year ago Purchase by Burke Whitman of 1500 shares of Amicus Therapeutics | ||
Burke Whitman over a year ago Purchase by Burke Whitman of 1500 shares of Amicus Therapeutics |
Omega Healthcare Management Efficiency
The company has Return on Asset of 0.039 % which means that on every $100 spent on assets, it made $0.039 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0867 %, implying that it generated $0.0867 on every 100 dollars invested. Omega Healthcare's management efficiency ratios could be used to measure how well Omega Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.03. The current Return On Capital Employed is estimated to decrease to 0.08. As of now, Omega Healthcare's Other Current Assets are decreasing as compared to previous years. The Omega Healthcare's current Intangibles To Total Assets is estimated to increase to 0.07, while Other Assets are projected to decrease to under 1.1 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Robert McCabe | National Health Investors | 70 | |
| James Shelton | Ventas Inc | 66 | |
| Robert Reed | Ventas Inc | 68 | |
| Nancy Agee | Healthcare Realty Trust | 68 | |
| Robert Adams | National Health Investors | 74 | |
| Roxanne Martino | Ventas Inc | 63 | |
| Timothy Triche | LTC Properties | 75 | |
| Kimberly Ouimet | National Health Investors | N/A | |
| Huiqi Zhang | Global Medical REIT | 31 | |
| Peter Lyew | LTC Properties | 66 | |
| Roscoe Moore | Global Medical REIT | 76 | |
| Sean Nolan | Ventas Inc | 52 | |
| Matthew Lustig | Ventas Inc | 59 | |
| James Morey | Universal Health Realty | 52 | |
| Boyd Hendrickson | LTC Properties | 75 | |
| Colleen Schaller | National Health Investors | N/A | |
| Bruce Sullivan | Healthcare Realty Trust | 79 | |
| Ronald Marston | Global Medical REIT | 78 | |
| Matthew Cypher | Global Medical REIT | 44 | |
| Henry Cole | Global Medical REIT | 76 | |
| Christann Vasquez | Healthcare Realty Trust | 60 | |
Management Performance
| Return On Equity | 0.0867 | ||||
| Return On Asset | 0.039 |
Omega Healthcare Inv Leadership Team
Elected by the shareholders, the Omega Healthcare's board of directors comprises two types of representatives: Omega Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Omega. The board's role is to monitor Omega Healthcare's management team and ensure that shareholders' interests are well served. Omega Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Omega Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Taylor CPA, CEO Director | ||
| Gail JD, Chief Counsel | ||
| Matthew Gourmand, IR Contact Officer | ||
| Kapila Anand, Independent Director | ||
| Neal Ballew, Senior Vice President Chief Accounting Officer | ||
| Burke Whitman, Independent Director | ||
| Edward Lowenthal, Independent Director | ||
| Craig Callen, Independent Chairman of the Board | ||
| Samuel Kovitz, Senior VP | ||
| C Pickett, Chief Executive Officer, Director | ||
| Daniel Booth, Chief Operating Officer | ||
| Kevin Jacobs, Independent Director | ||
| Megan Krull, Senior Operations | ||
| Michele Reber, Director Management | ||
| Robert Stephenson, Chief Financial Officer | ||
| Steven Insoft, Chief Corporate Development Officer | ||
| Michael Ritz, Chief Accounting Officer | ||
| Gail Makode, Chief Legal Officer, General Counsel | ||
| Stephen Plavin, Independent Director | ||
| Matthew CPA, Senior Relations | ||
| Barbara Hill, Independent Director | ||
| Lisa EgbuonuDavis, Director | ||
| Vikas Gupta, Senior Development |
Omega Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Omega Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0867 | ||||
| Return On Asset | 0.039 | ||||
| Profit Margin | 0.34 % | ||||
| Operating Margin | 0.66 % | ||||
| Current Valuation | 15.49 B | ||||
| Shares Outstanding | 269.95 M | ||||
| Shares Owned By Insiders | 0.28 % | ||||
| Shares Owned By Institutions | 73.77 % | ||||
| Number Of Shares Shorted | 11.04 M | ||||
| Price To Earning | 30.17 X |
Currently Active Assets on Macroaxis
When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.137 | Dividend Share 2.68 | Earnings Share 1.36 | Revenue Per Share 4.03 | Quarterly Revenue Growth 0.14 |
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.